Workflow
Micron Rides AI Wave With Upgraded Outlook, Analysts See More Gains Ahead
Benzinga· 2025-08-12 16:47
Micron Technology MU extended gains Tuesday after boosting its August-quarter outlook, fueled by surging demand and pricing for AI-focused memory chips, signaling continued momentum in the DRAM market through 2026.JP Morgan analyst Harlan Sur maintained Micron Technology MU with an Overweight rating and raised the price forecast from $165 to $185 on Monday.Sur said Micron delivered a positive pre-announcement for its August quarter, raising revenue, gross margin, and EPS guidance on stronger-than-expected D ...
FXI: The Prospects For Chinese Stocks (Rating Upgrade)
Seeking Alpha· 2025-08-12 16:47
The Hecht Commodity Report is one of the most comprehensive commodities reports available today from a top-ranked author in commodities, forex, and precious metals. My weekly report covers the market movements of over 29 different commodities and provides bullish, bearish, and neutral calls, directional trading recommendations, and actionable ideas for traders and investors.He runs the investing group The Hecht Commodity Report , one of the most comprehensive commodities services available. It covers the ma ...
Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally
Seeking Alpha· 2025-08-12 16:46
David focuses on growth & momentum stocks that are reasonably priced and likely to outperform the market over the long-term. He is a long term investor of quality stocks and uses options for strategy. David told investors to buy in March 2009 at the bottom of the financial crisis. The S&P 500 increased 367% and the Nasdaq increased 685% from 2009 through 2019. He wants to help make people money by investing in high-quality growth stocks.Analyst’s Disclosure:I/we have a beneficial long position in the shares ...
Reasons to Add Veeva Systems Stock to Your Portfolio for Now
ZACKS· 2025-08-12 16:46
Key Takeaways Veeva sees growth from Vault CRM migration, AI tools and expanding Clinical Development Cloud.Strategic deals include Boehringers CRM migration and a Walgreens partnership for clinical research.Q1 fiscal 2026 earnings and revenues beat estimates, led by subscription and professional services.Veeva Systems Inc. (VEEV) is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid first-quarter fiscal 2026 performance and strategic deals, ...
Genie Energy Q2 Earnings Decline Y/Y Amid Squeezed Margins
ZACKS· 2025-08-12 16:46
Shares of Genie Energy Ltd. (GNE) have declined 18.3% since reporting results for the second quarter of 2025, lagging the S&P 500 index’s 0.4% rise in the same period. Over the past month, the stock has fallen 26.1% against the S&P 500’s 3.7% advance. This contrasting trend highlights strong initial investor enthusiasm following the results, tempered by a subsequent pullback amid broader market strength.Earnings & Revenue EstimatesGenie Energy’s second-quarter 2025 revenues rose 16% year over year to $105.3 ...
NTES Set to Report Q2 Earnings: What's in Store for the Stock?
ZACKS· 2025-08-12 16:46
Key Takeaways The Zacks Consensus Estimate for Q2 EPS stands at $2.04, up from $1.66 last year.Gaming strength fueled by Marvel Rivals, FragPunk and Once Human launches.Challenges persist in learning, music and innovative business segments.NetEase (NTES) is scheduled to release second-quarter 2025 results on Aug. 14.The Zacks Consensus Estimate for NTES’ second-quarter revenues is pegged at $3.86 billion, indicating 10.02% year-over-year growth.The consensus mark for earnings is pegged at $2.04 per share, w ...
SMMT Q2 Loss Wider Than Expected, Ivonescimab Studies in Focus
ZACKS· 2025-08-12 16:46
Key Takeaways SMMT's Q2 loss per share widened to $0.76, missing the consensus estimate of a loss of $0.10.Higher R&D costs stemmed from expanded ivonescimab trials for non-small cell lung cancer.FDA requires OS benefit before approving ivonescimab-chemo for EGFR-mutated lung cancer.Summit Therapeutics (SMMT) reported second-quarter 2025 loss per share of 76 cents, much wider than the Zacks Consensus Estimate of a loss of 10 cents. In the year-ago period, the company had incurred a loss of 9 cents.The repor ...
Where Food Comes From Q2 Earnings Rise Y/Y Despite Margin Pressures
ZACKS· 2025-08-12 16:46
Shares of Where Food Comes From, Inc. (WFCF) have declined 0.8% since reporting results for the second quarter of 2025. This compares with the S&P 500 index’s 0.7% growth over the same period. Over the past month, the stock has fallen 6.7%, underperforming the S&P 500’s 2.3% rally.For the quarter ended June 30, 2025, total revenues rose 3% year over year to $6.6 million, driven by modest growth in verification and certification services and an increase in product sales. Verification and certification revenu ...
Why Sun Life (SLF) is a Great Dividend Stock Right Now
ZACKS· 2025-08-12 16:46
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a metric that mea ...
Veritex Holdings (VBTX) Could Be a Great Choice
ZACKS· 2025-08-12 16:46
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a ...